News Medical on MSN8d
FXR cyclic peptide antagonists as a novel strategy for MASH treatmentIn this study, the authors first used an AlphaScreen assay to identify a series of tryptophan-based cyclic peptide compounds with FXR-antagonistic activity, specifically those modified with a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback